SVRA
Savara IncCompany Information
- Company Name
- Savara Inc
- CIK
- CIK0001160308
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- SVRA: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- SVRA
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-06-20
- Last sale
- 2026-06-22
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 414,528
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 218,003,293
- Shares outstanding
- 253,569,891
- Ownership
- 85.97%
Earnings Market Reaction
- Filing date
- 2026-08-11
- Price on filing date
- —
- 1-month reaction
- -3.59%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 42 | 39 | 33 | 16 | 17 | 20 | 15 | 21 | 24 | 17 | 27 | 28 | ||||||
| Short Term Investments | 131 | 164 | 203 | 108 | 129 | 153 | 181 | 198 | 98 | 126 | 136 | 141 | ||||||
| Prepaid Expense And Other Assets Current | 5 | 6 | 6 | 4 | 5 | 5 | 6 | 7 | 6 | 3 | 4 | 2 | ||||||
| Assets Current | 178 | 209 | 242 | 128 | 151 | 177 | 202 | 226 | 128 | 146 | 166 | 170 | ||||||
| Property Plant And Equipment Net | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 2 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | ||||||
| Assets | 192 | 222 | 253 | 141 | 164 | 189 | 213 | 239 | 140 | 158 | 178 | 182 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 7 | 4 | 6 | 4 | 5 | 6 | 5 | 5 | 3 | 3 | 4 | 3 | ||||||
| Accrued Liabilities Current | 11 | 11 | 15 | 13 | 9 | 6 | 10 | 8 | 8 | 7 | 7 | 6 | ||||||
| Long Term Debt Current | - | - | - | - | - | 0 | - | - | - | - | - | - | ||||||
| Liabilities Current | 18 | 16 | 20 | 17 | 14 | 12 | 15 | 13 | 11 | 10 | 11 | 9 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Long Term Debt Noncurrent | 30 | 30 | 30 | 30 | 30 | 30 | 27 | 27 | 26 | 26 | 26 | 26 | ||||||
| Other Liabilities Noncurrent | 1 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 48 | 46 | 50 | 47 | 43 | 41 | 41 | 39 | 38 | 36 | 37 | 36 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 830 | 822 | 811 | 670 | 667 | 664 | 661 | 659 | 538 | 536 | 534 | 525 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -1 | -0 | -0 | -0 | -0 | -1 | -1 | 0 | -1 | -1 | -0 | -1 | ||||||
| Retained Earnings Accumulated Deficit | -686 | -645 | -608 | -576 | -546 | -516 | -489 | -460 | -436 | -414 | -393 | -377 | ||||||
| Stockholders Equity | 144 | 176 | 203 | 94 | 120 | 148 | 171 | 199 | 102 | 122 | 140 | 147 | ||||||
| Liabilities And Stockholders Equity | 192 | 222 | 253 | 141 | 164 | 189 | 213 | 239 | 140 | 158 | 178 | 182 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 600 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 205 | 205 | 205 | - | 173 | 173 | 172 | 171 | 138 | 138 | 138 | 135 | ||||||
| Shares Outstanding | 205 | 205 | 205 | - | 173 | 173 | 172 | 171 | 138 | 138 | 138 | 135 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialSavara Inc (SVRA) — SEC Financial Statements & Analysis
Savara Inc (SVRA) is a pharmaceutical preparations company, incorporated in DE. Savara Inc trades on Nasdaq as: SVRA. Savara Inc (SVRA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11. Based on that filing, Savara Inc carries a market cap of $1.56B, a P/E ratio of -11.21x, a P/B ratio of 10.87x, an enterprise value of $1.55B, and an EV/EBITDA multiple of -10.80x. On profitability, it posts a Return on Equity (ROE) of -105.48%, a Return on Assets (ROA) of -78.28%, and a Return on Invested Capital (ROIC) of -108.53%. Per share, it reports EPS of $-0.55, diluted EPS of $-0.55, free cash flow per share of $-0.44, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 26.26% year-over-year and EPS growth of 7.77% year-over-year. On the balance sheet, it maintains a current ratio of 10.13x, a quick ratio of 9.83x, working capital of $160.72M, a debt-to-equity ratio of 0.34x, a debt ratio of 0.25, an interest coverage ratio of -39.58x, free cash flow of $-110.66M (TTM), and net debt of $-11.69M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.56B
- P/E TTM
- -11.21x
- EPS TTM
- $-0.55
- P/B TTM
- 10.87x
- ROE TTM
- -105.48%
- ROA TTM
- -78.28%
- Debt To Equity
- 0.34x
- Free Cash Flow TTM
- $-110.66M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Savara Inc in?
Savara Inc (SVRA) operates in the Pharmaceutical Preparations industry.
What exchange does SVRA trade on?
Savara Inc (SVRA) trades on the Nasdaq.
Where is Savara Inc incorporated?
Savara Inc is incorporated in DE.
When was Savara Inc (SVRA)'s most recent SEC filing?
Savara Inc (SVRA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11.
What is SVRA's market cap?
Savara Inc (SVRA) has a market capitalization of $1.56B as of 2026-06-30.
What is SVRA's EPS (earnings per share)?
Savara Inc (SVRA)'s trailing twelve month EPS is $-0.55 as of 2026-06-30.
What is SVRA's ROE (return on equity)?
Savara Inc (SVRA)'s trailing twelve month Return on Equity (ROE) is -105.48% as of 2026-06-30.
What is SVRA's ROA (return on assets)?
Savara Inc (SVRA)'s trailing twelve month Return on Assets (ROA) is -78.28% as of 2026-06-30.
What is SVRA's ROIC (return on invested capital)?
Savara Inc (SVRA)'s trailing twelve month Return on Invested Capital (ROIC) is -108.53% as of 2026-06-30.
What is SVRA's EV/EBITDA?
Savara Inc (SVRA)'s trailing twelve month EV/EBITDA is -10.80x as of 2026-06-30.